Review



codon-optimized sequences for human gdf11 and human gdf11pro-fc  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GenScript corporation codon-optimized sequences for human gdf11 and human gdf11pro-fc
    Codon Optimized Sequences For Human Gdf11 And Human Gdf11pro Fc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/codon+optimized+sequences+for+human+gdf11+and+human+gdf11pro+fc/pmc06537384-52-8-12
    Average 90 stars, based on 1 article reviews
    codon-optimized sequences for human gdf11 and human gdf11pro-fc - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
    Article Snippet: 126 127 MATERIALS & METHODS 128 Chemicals-Adenosine-5’-triphosphate disodium, Adenosine-5’-diphosphate disodium, 129 Adenosine-5’-monophosphate disodium, Uridine-5’-triphosphate trisodium, Uridine-5’-130 diphosphate disodium, and Uridine-5’-monophosphate disodium, TRAP6, Chrono-log, Collagen 131 P/N 385, malachite green hydrochloride, ammonium molybdate, Polyoxyethylene 10 Lauryl 132 Ether, and sodium citrate dihydrate were purchased from Millipore Sigma (St. Louis, MO).

    Sequencing:

    Article Title: A doubly auxotrophic CHO-K1 cell line for the production of recombinant monoclonal antibodies.
    Article Snippet: CHO cells are the most widely used mammalian hosts for recombinant protein production due to their hardiness, ease of transfection, and production of glycan structures similar to those in natural human mAbs.. To enhance the usefulness of CHO-K1 cells we developed a new selection system based on double auxotrophy.. We used CRISPR-Cas9 to knockout the genes that encode the bifunctional enzymes catalyzing the last two steps in the de novo synthesis of pyrimidines and purines (uridine monophosphate synthetase (UMPS) and 5aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), respectively).

    Synthesized:

    Article Title: A doubly auxotrophic CHO-K1 cell line for the production of recombinant monoclonal antibodies.
    Article Snippet: CHO cells are the most widely used mammalian hosts for recombinant protein production due to their hardiness, ease of transfection, and production of glycan structures similar to those in natural human mAbs.. To enhance the usefulness of CHO-K1 cells we developed a new selection system based on double auxotrophy.. We used CRISPR-Cas9 to knockout the genes that encode the bifunctional enzymes catalyzing the last two steps in the de novo synthesis of pyrimidines and purines (uridine monophosphate synthetase (UMPS) and 5aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), respectively).

    Clone Assay:

    Article Title: A doubly auxotrophic CHO-K1 cell line for the production of recombinant monoclonal antibodies.
    Article Snippet: CHO cells are the most widely used mammalian hosts for recombinant protein production due to their hardiness, ease of transfection, and production of glycan structures similar to those in natural human mAbs.. To enhance the usefulness of CHO-K1 cells we developed a new selection system based on double auxotrophy.. We used CRISPR-Cas9 to knockout the genes that encode the bifunctional enzymes catalyzing the last two steps in the de novo synthesis of pyrimidines and purines (uridine monophosphate synthetase (UMPS) and 5aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), respectively).



    Similar Products

    94
    R&D Systems human fc sequence
    Human Fc Sequence, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/Recombinant+Human+CD155%2FPVR+Fc+Chimera+Protein%2C+CF/us12415854-917-10-15
    Average 94 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher synthetic gene coding fusion hil-7 sequence sequence human igg2-fc
    Synthetic Gene Coding Fusion Hil 7 Sequence Sequence Human Igg2 Fc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pm35667841-50-16-20
    Average 90 stars, based on 1 article reviews
    synthetic gene coding fusion hil-7 sequence sequence human igg2-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Antagen Pharmaceuticals a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc,
    A Scfv Higg1 Construct, Where Its Scfv Part Utilizes Anti Tnfα Humira Sequence To Fuse With Human Igg1 Fc,, supplied by Antagen Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/anti+mcd79b+pig+igg/pmc08315562-62-5-23
    Average 90 stars, based on 1 article reviews
    a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc, - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Bioneer Corporation human igg1 fc coding sequence
    Human Igg1 Fc Coding Sequence, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/humanized+igg1+ab+antibody/10__34172_slash_ps__2020__37-24-15-18
    Average 90 stars, based on 1 article reviews
    human igg1 fc coding sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Twist Bioscience igg1 human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Igg1 Human Fc Sequence, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/ptwist+amp+high+copy/pmc07587116-45-3-19
    Average 90 stars, based on 1 article reviews
    igg1 human fc sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc 4800 human genes
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    4800 Human Genes, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/pmc07322863-25-4-11
    Average 96 stars, based on 1 article reviews
    4800 human genes - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    InvivoGen human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Fc Sequence, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pFUSE-hIgG2-Fc2/us10562980-2235-10-21
    Average 97 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    90
    GenScript corporation codon-optimized sequences for human gdf11 and human gdf11pro-fc
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Codon Optimized Sequences For Human Gdf11 And Human Gdf11pro Fc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/codon+optimized+sequences+for+human+gdf11+and+human+gdf11pro+fc/pmc06537384-52-8-12
    Average 90 stars, based on 1 article reviews
    codon-optimized sequences for human gdf11 and human gdf11pro-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc human disease
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Disease, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/10__3233_slash_jnd___189001-6817-10-17
    Average 96 stars, based on 1 article reviews
    human disease - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Journal: Journal of Clinical Microbiology

    Article Title: SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

    doi: 10.1128/JCM.01533-20

    Figure Lengend Snippet: Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Article Snippet: DNA encoding the IgG1 human Fc sequence was added to the C terminus of the huACE2 and cloned by Twist Bioscience into a modified mammalian pVax-1 expression plasmid to generate the recombinant plasmid ACE2-IgHu.

    Techniques: Blocking Assay, Binding Assay, Concentration Assay, Purification